Report cover image

Global Therapeutic Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 195 Pages
SKU # APRC20552924

Description

Summary

According to APO Research, The global Therapeutic Radiopharmaceuticals market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Therapeutic Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Therapeutic Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Therapeutic Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Therapeutic Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Therapeutic Radiopharmaceuticals include Aurobindo Pharma, China Isotope & Radiation, Curium Pharmaceuticals, Dongcheng, International Isotopes, Jubilant Radiopharma, Lantheus, Mundipharma and Q BioMed, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Therapeutic Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Therapeutic Radiopharmaceuticals, also provides the sales of main regions and countries. Of the upcoming market potential for Therapeutic Radiopharmaceuticals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Therapeutic Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Therapeutic Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.

Therapeutic Radiopharmaceuticals Segment by Company

Aurobindo Pharma
China Isotope & Radiation
Curium Pharmaceuticals
Dongcheng
International Isotopes
Jubilant Radiopharma
Lantheus
Mundipharma
Q BioMed
Bayer
Novartis
Therapeutic Radiopharmaceuticals Segment by Type

Lutetium-177
Radium-223
Iodine-131
Other
Therapeutic Radiopharmaceuticals Segment by Application

Bone Metastasis
Thyroid
Lymphoma
Other
Therapeutic Radiopharmaceuticals Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Therapeutic Radiopharmaceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Therapeutic Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Therapeutic Radiopharmaceuticals Market Size, 2020 VS 2024 VS 2031
1.3 Global Therapeutic Radiopharmaceuticals Market Size Estimates and Forecasts (2020-2031)
1.4 Global Therapeutic Radiopharmaceuticals Sales Estimates and Forecasts (2020-2031)
1.5 Global Therapeutic Radiopharmaceuticals Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Therapeutic Radiopharmaceuticals Market Dynamics
2.1 Therapeutic Radiopharmaceuticals Industry Trends
2.2 Therapeutic Radiopharmaceuticals Industry Drivers
2.3 Therapeutic Radiopharmaceuticals Industry Opportunities and Challenges
2.4 Therapeutic Radiopharmaceuticals Industry Restraints
3 Therapeutic Radiopharmaceuticals Market by Manufacturers
3.1 Global Therapeutic Radiopharmaceuticals Revenue by Manufacturers (2020-2025)
3.2 Global Therapeutic Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.3 Global Therapeutic Radiopharmaceuticals Average Sales Price by Manufacturers (2020-2025)
3.4 Global Therapeutic Radiopharmaceuticals Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Therapeutic Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Therapeutic Radiopharmaceuticals Manufacturers, Product Type & Application
3.7 Global Therapeutic Radiopharmaceuticals Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Therapeutic Radiopharmaceuticals Market CR5 and HHI
3.8.2 Global Top 5 and 10 Therapeutic Radiopharmaceuticals Players Market Share by Revenue in 2024
3.8.3 2024 Therapeutic Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Therapeutic Radiopharmaceuticals Market by Type
4.1 Therapeutic Radiopharmaceuticals Type Introduction
4.1.1 Lutetium-177
4.1.2 Radium-223
4.1.3 Iodine-131
4.1.4 Other
4.2 Global Therapeutic Radiopharmaceuticals Sales by Type
4.2.1 Global Therapeutic Radiopharmaceuticals Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Therapeutic Radiopharmaceuticals Sales by Type (2020-2031)
4.2.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2020-2031)
4.3 Global Therapeutic Radiopharmaceuticals Revenue by Type
4.3.1 Global Therapeutic Radiopharmaceuticals Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Therapeutic Radiopharmaceuticals Revenue by Type (2020-2031)
4.3.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2020-2031)
5 Therapeutic Radiopharmaceuticals Market by Application
5.1 Therapeutic Radiopharmaceuticals Application Introduction
5.1.1 Bone Metastasis
5.1.2 Thyroid
5.1.3 Lymphoma
5.1.4 Other
5.2 Global Therapeutic Radiopharmaceuticals Sales by Application
5.2.1 Global Therapeutic Radiopharmaceuticals Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Therapeutic Radiopharmaceuticals Sales by Application (2020-2031)
5.2.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2020-2031)
5.3 Global Therapeutic Radiopharmaceuticals Revenue by Application
5.3.1 Global Therapeutic Radiopharmaceuticals Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Therapeutic Radiopharmaceuticals Revenue by Application (2020-2031)
5.3.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2020-2031)
6 Global Therapeutic Radiopharmaceuticals Sales by Region
6.1 Global Therapeutic Radiopharmaceuticals Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Therapeutic Radiopharmaceuticals Sales by Region (2020-2031)
6.2.1 Global Therapeutic Radiopharmaceuticals Sales by Region (2020-2025)
6.2.2 Global Therapeutic Radiopharmaceuticals Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Therapeutic Radiopharmaceuticals Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Therapeutic Radiopharmaceuticals Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Therapeutic Radiopharmaceuticals Revenue by Region
7.1 Global Therapeutic Radiopharmaceuticals Revenue by Region
7.1.1 Global Therapeutic Radiopharmaceuticals Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Therapeutic Radiopharmaceuticals Revenue by Region (2020-2025)
7.1.3 Global Therapeutic Radiopharmaceuticals Revenue by Region (2026-2031)
7.1.4 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Therapeutic Radiopharmaceuticals Revenue (2020-2031)
7.2.2 North America Therapeutic Radiopharmaceuticals Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Therapeutic Radiopharmaceuticals Revenue (2020-2031)
7.3.2 Europe Therapeutic Radiopharmaceuticals Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Therapeutic Radiopharmaceuticals Revenue (2020-2031)
7.4.2 Asia-Pacific Therapeutic Radiopharmaceuticals Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Therapeutic Radiopharmaceuticals Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Therapeutic Radiopharmaceuticals Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Aurobindo Pharma
8.1.1 Aurobindo Pharma Comapny Information
8.1.2 Aurobindo Pharma Business Overview
8.1.3 Aurobindo Pharma Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Aurobindo Pharma Therapeutic Radiopharmaceuticals Product Portfolio
8.1.5 Aurobindo Pharma Recent Developments
8.2 China Isotope & Radiation
8.2.1 China Isotope & Radiation Comapny Information
8.2.2 China Isotope & Radiation Business Overview
8.2.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product Portfolio
8.2.5 China Isotope & Radiation Recent Developments
8.3 Curium Pharmaceuticals
8.3.1 Curium Pharmaceuticals Comapny Information
8.3.2 Curium Pharmaceuticals Business Overview
8.3.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product Portfolio
8.3.5 Curium Pharmaceuticals Recent Developments
8.4 Dongcheng
8.4.1 Dongcheng Comapny Information
8.4.2 Dongcheng Business Overview
8.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Dongcheng Therapeutic Radiopharmaceuticals Product Portfolio
8.4.5 Dongcheng Recent Developments
8.5 International Isotopes
8.5.1 International Isotopes Comapny Information
8.5.2 International Isotopes Business Overview
8.5.3 International Isotopes Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 International Isotopes Therapeutic Radiopharmaceuticals Product Portfolio
8.5.5 International Isotopes Recent Developments
8.6 Jubilant Radiopharma
8.6.1 Jubilant Radiopharma Comapny Information
8.6.2 Jubilant Radiopharma Business Overview
8.6.3 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product Portfolio
8.6.5 Jubilant Radiopharma Recent Developments
8.7 Lantheus
8.7.1 Lantheus Comapny Information
8.7.2 Lantheus Business Overview
8.7.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Lantheus Therapeutic Radiopharmaceuticals Product Portfolio
8.7.5 Lantheus Recent Developments
8.8 Mundipharma
8.8.1 Mundipharma Comapny Information
8.8.2 Mundipharma Business Overview
8.8.3 Mundipharma Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Mundipharma Therapeutic Radiopharmaceuticals Product Portfolio
8.8.5 Mundipharma Recent Developments
8.9 Q BioMed
8.9.1 Q BioMed Comapny Information
8.9.2 Q BioMed Business Overview
8.9.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Q BioMed Therapeutic Radiopharmaceuticals Product Portfolio
8.9.5 Q BioMed Recent Developments
8.10 Bayer
8.10.1 Bayer Comapny Information
8.10.2 Bayer Business Overview
8.10.3 Bayer Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Bayer Therapeutic Radiopharmaceuticals Product Portfolio
8.10.5 Bayer Recent Developments
8.11 Novartis
8.11.1 Novartis Comapny Information
8.11.2 Novartis Business Overview
8.11.3 Novartis Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Novartis Therapeutic Radiopharmaceuticals Product Portfolio
8.11.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Therapeutic Radiopharmaceuticals Value Chain Analysis
9.1.1 Therapeutic Radiopharmaceuticals Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Therapeutic Radiopharmaceuticals Production Mode & Process
9.2 Therapeutic Radiopharmaceuticals Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Therapeutic Radiopharmaceuticals Distributors
9.2.3 Therapeutic Radiopharmaceuticals Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.